DK1374891T3 - Fremgangsmåde til fremskyndelse af hastigheden af mucociliær clearance - Google Patents

Fremgangsmåde til fremskyndelse af hastigheden af mucociliær clearance

Info

Publication number
DK1374891T3
DK1374891T3 DK03018789T DK03018789T DK1374891T3 DK 1374891 T3 DK1374891 T3 DK 1374891T3 DK 03018789 T DK03018789 T DK 03018789T DK 03018789 T DK03018789 T DK 03018789T DK 1374891 T3 DK1374891 T3 DK 1374891T3
Authority
DK
Denmark
Prior art keywords
accelerating
rate
mucociliary clearance
mucociliary
clearance
Prior art date
Application number
DK03018789T
Other languages
Danish (da)
English (en)
Inventor
Roderick Hall
Christopher T Poll
Benjamin B Newton
William J A Taylor
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of DK1374891T3 publication Critical patent/DK1374891T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
DK03018789T 1998-12-22 1999-12-22 Fremgangsmåde til fremskyndelse af hastigheden af mucociliær clearance DK1374891T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21891398A 1998-12-22 1998-12-22
US44196699A 1999-11-17 1999-11-17
PCT/GB1999/004381 WO2000037099A2 (en) 1998-12-22 1999-12-22 Method for accelerating the rate of mucociliary clearance by using a kunitz-type serine protease inhibitor

Publications (1)

Publication Number Publication Date
DK1374891T3 true DK1374891T3 (da) 2009-01-26

Family

ID=26913378

Family Applications (2)

Application Number Title Priority Date Filing Date
DK03018789T DK1374891T3 (da) 1998-12-22 1999-12-22 Fremgangsmåde til fremskyndelse af hastigheden af mucociliær clearance
DK99963636T DK1140150T3 (da) 1998-12-22 1999-12-22 Fremgangsmåde til accelerering af hastigheden af mucociliær clearance under anvendelse af en serinproteaseinhibitor af Kunitz-type

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK99963636T DK1140150T3 (da) 1998-12-22 1999-12-22 Fremgangsmåde til accelerering af hastigheden af mucociliær clearance under anvendelse af en serinproteaseinhibitor af Kunitz-type

Country Status (13)

Country Link
US (1) US20070086956A1 (ja)
EP (2) EP1374891B1 (ja)
JP (2) JP3819239B2 (ja)
CN (1) CN1229138C (ja)
AR (1) AR030257A1 (ja)
AT (2) ATE254473T1 (ja)
AU (1) AU758832B2 (ja)
CA (1) CA2356404C (ja)
DE (2) DE69912988T2 (ja)
DK (2) DK1374891T3 (ja)
ES (2) ES2318075T3 (ja)
TW (1) TWI249406B (ja)
WO (1) WO2000037099A2 (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7244616B2 (en) 2003-06-27 2007-07-17 Bayer Pharmaceuticals Corporation Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells
CN1332715C (zh) * 2003-09-09 2007-08-22 王继峰 蛋白酶抑制剂在制备预防和治疗肺部疾病的药物中的用途
EP1586587A1 (en) * 2004-04-16 2005-10-19 Exonhit Therapeutics SA Compositions and methods for detecting angiogenesis
GB0411145D0 (en) * 2004-05-19 2004-06-23 Imp College Innovations Ltd Protease inhibitors and their therapeutic applications
CN100408094C (zh) * 2005-08-29 2008-08-06 吉林圣元科技有限责任公司 蛋白酶抑制剂在保护肝细胞功能中的应用
CA2663795A1 (en) * 2006-09-19 2008-03-27 Discovery Laboratories, Inc. Pulmonary surfactant formulations and methods for promoting mucus clearance
EP2854833A1 (en) * 2012-05-25 2015-04-08 Inserm Agents for treating cystic fibrosis
JP2016204360A (ja) * 2015-02-25 2016-12-08 エー１エム ファーマ エービーＡ１Ｍ Ｐｈａｒｍａ ＡＢ 放射性核種療法における腎臓の保護に用いるためのアルファ−１−ミクログロブリン

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223482A (en) * 1986-11-17 1993-06-29 Scios Nova Inc. Recombinant Alzheimer's protease inhibitory amyloid protein and method of use
US5106833A (en) * 1987-07-23 1992-04-21 Washington University Coagulation inhibitors
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5663143A (en) * 1988-09-02 1997-09-02 Dyax Corp. Engineered human-derived kunitz domains that inhibit human neutrophil elastase
DE59007737D1 (de) * 1989-05-13 1995-01-05 Bayer Ag Proteinaseninhibitoren, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel.
DK408089D0 (da) * 1989-08-18 1989-08-18 Novo Nordisk As Proteiner
EP1325931B1 (en) * 1991-03-01 2009-05-13 Dyax Corporation Inhibitors of human neutrophil elastase
RU2054180C1 (ru) * 1991-08-21 1996-02-10 Жирнов Олег Петрович (н/п) Способ лечения вирусных респираторных инфекций
IL104325A (en) * 1992-01-07 2000-10-31 Novo Nordisk As Variants of human kunitz-type protease inhibitor domain II of tissue factor pathway inhibitor (TFPI) pharmaceutical compositions containing them a DNA construct encoding them their expression vectors a cell containing said DNA constructs and methods for the production of all the above
WO1994001461A1 (en) * 1992-07-13 1994-01-20 Corvas International, Inc. BOVINE PANCREATIC TRYPSIN INHIBITOR DERIVED INHIBITORS OF FACTOR Xa
US5436153A (en) * 1992-12-02 1995-07-25 Sprecher; Cindy A. Human amyloid protein precursor homolog and Kunitz-type inhibitor
AU5684594A (en) * 1992-12-02 1994-06-22 Novo Nordisk A/S Novel human amyloid protein precursor homologue and kunitz-type inhibitors
JP2769083B2 (ja) * 1993-02-22 1998-06-25 日清食品株式会社 エラスターゼ阻害活性を有する新規ペプチドおよびその製造方法
US5455338A (en) * 1993-11-05 1995-10-03 Zymogenetics, Inc. DNA encoding novel human kunitz-type inhibitors and methods relating thereto
PT739355E (pt) * 1994-01-11 2005-01-31 Dyax Corp Proteinas de 'dominio de kunitz' inibidoras de calicreina e seus analogos
US5795954A (en) * 1994-03-04 1998-08-18 Genentech, Inc. Factor VIIa inhibitors from Kunitz domain proteins
US5786328A (en) * 1995-06-05 1998-07-28 Genentech, Inc. Use of kunitz type plasma kallikrein inhibitors
EP0758682B1 (en) * 1995-07-24 2004-05-12 Mitsubishi Chemical Corporation Hepatocyte growth factor activator inhibitor
US5736364A (en) * 1995-12-04 1998-04-07 Genentech, Inc. Factor viia inhibitors
BR9708021A (pt) * 1996-03-11 1999-07-27 Bayer Ag Proteína substancialmente purificada composição farmacêutica sequência de ácido nucleico isolada vetor de express o de protéina auto-replicante e processos para inibir a atividade de protéinas de serina tratar uma condição e preparar um medicamento de uma proteína
US20070140979A1 (en) * 1998-12-22 2007-06-21 Bayer Aktiengesellschaft Method for accelerating the rate of mucociliary clearance

Also Published As

Publication number Publication date
EP1374891A1 (en) 2004-01-02
EP1140150B1 (en) 2003-11-19
EP1140150A2 (en) 2001-10-10
DE69939559D1 (de) 2008-10-23
WO2000037099A3 (en) 2000-10-26
ES2318075T3 (es) 2009-05-01
JP2006232810A (ja) 2006-09-07
CA2356404A1 (en) 2000-06-29
ATE254473T1 (de) 2003-12-15
TWI249406B (en) 2006-02-21
CN1334743A (zh) 2002-02-06
CA2356404C (en) 2010-03-30
AR030257A1 (es) 2003-08-20
AU1987800A (en) 2000-07-12
EP1374891B1 (en) 2008-09-10
ES2209542T3 (es) 2004-06-16
DE69912988T2 (de) 2004-11-11
DE69912988D1 (de) 2003-12-24
DK1140150T3 (da) 2004-03-22
ATE407694T1 (de) 2008-09-15
AU758832B2 (en) 2003-04-03
US20070086956A1 (en) 2007-04-19
JP3819239B2 (ja) 2006-09-06
CN1229138C (zh) 2005-11-30
JP2002532558A (ja) 2002-10-02
WO2000037099A2 (en) 2000-06-29

Similar Documents

Publication Publication Date Title
DK1016836T3 (da) Fremgangsmåde til tilvejebringelse af köling
DK1077940T3 (da) 4-Phenylpiperidiner til behandling af pruritiske dermatoser
DK1772141T3 (da) Fremgangsmåde til gennemföring af krystallisation i fast tilstand
DE69938817D1 (de) Erstellungsverfahren
DE59910525D1 (de) Operationssystem
DK1085981T3 (da) Fremgangsmåde til emballering
IT1315269B1 (it) Metodo per la preparazione di 5-cianoftalide
DE69935481D1 (de) Kälteanlage
DK0937055T3 (da) Fremgangsmåde til fremstilling af d,I-alfa-tocopherol
DE69930732D1 (de) Kälteanlage
NL1013360A1 (nl) Bouwkundige afscherming.
DK0917879T3 (da) Forbedret fremgangsmåde til stabilisering af proteiner
IT1315237B1 (it) Metodo di produzione di tagliolini secchi.
BR9907304B1 (pt) refratÁrio de alumina-magnÉsia-grafita.
ID28966A (id) Metoda pemurnian trietanolamina
DE69942875D1 (de) Angriffs
FI980735A (fi) Viiveenhallintamenetelmä
DK1374891T3 (da) Fremgangsmåde til fremskyndelse af hastigheden af mucociliær clearance
DK0987356T3 (da) Fremgangsmåde til trækning
NO20006531D0 (no) Kontrollmetode
DK0864564T3 (da) Særlig fremgangsmåde til fremstillingen af alfa-bromlactamderivater
DK0985733T3 (da) Fremgangsmåde til fremstilling af cyclodextrin
DK0927766T3 (da) Enzymatisk fremgangsmåde til fremstilling af (S)-cyanhydriner
DE69928197D1 (de) Atzverfahren
IT247560Y1 (it) Orologio.